The court said as Sebi had returned Digvijay Danny Gaekwad’s higher counteroffer, there was no other rival bid to match the ongoing open offer.

Religare Enterprises' independent directors are unhappy with the company's rapid announcement of Danny Gaekwad's late bid.

Care Health Insurance, India’s second-largest standalone health insurer and Religare’s most valuable asset, has been growing ...

The Delhi High Court on Thursday refused to stay the Annual General Meeting (AGM) of Religare Enterprises Limited (REL) scheduled for February 7, amid controver ...

India stock markets, on Wednesday, managed to inch higher despite volatility, gaining nearly 1 per cent amid mixed cues. The ...

Saluja wishes to prevent the proposal at the upcoming annual general meeting, aimed at appointing a director in her place at ...

Florida businessman Danny Gaekwad persists in his bid for control of Religare Enterprises, challenging the current open offer ...

Rashmi Saluja seeks Delhi High Court injunction against Religare Enterprises' board decision on her re-appointment.

Capital market regulator Sebi rejected the competing open offer made by the US-based entity Danny Gaekwad Developments & ...

Digvijay Laxmansinh Gaekwad, a Florida-based investor, is required to appoint a merchant banker to comply with Sebi's ...

Sebi has returned a letter from US based investors Digvijay Laxmansinh Gaekwad and Danny Gaekwad Developments & Investments, ...

Sebi has rejected the competing open offer for Religare Enterprises by Florida, US-based investor Digivijay ‘Danny’ ...